EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes

Tianyi Wang, Tong Gao, Masayoshi Fujisawa, Toshiaki Ohara iD, Masakiyo Sakaguchi iD, Teizo Yoshimura iD, Akihiro Matsukawa iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25116269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tianyi Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 70…. Hauptthemen laut MEDLINE: Autophagy, Carcinoma, Hepatocellular, Hepatocytes, Liver Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sprouty-related enabled/vasodilator-stimulated phosphoprotein homology 1 domain containing 2 (SPRED2) is an inhibitor of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway and has been shown to promote autophagy in several cancers. Here, we aimed to determine whether SPRED2 plays a role in autophagy in hepatocellular carcinoma (HCC) cells. The Cancer Genome Atlas (TCGA) Liver Cancer Database showed a negative association between the level of SPRED2 and p62, a ubiquitin-binding scaffold protein that accumulates when autophagy is inhibited. Immunohistochemically, accumulation of p62 was detected in human HCC tissues with low SPRED2 expression. Overexpression of SPRED2 in HCC cells increased the number of autophagosomes and autophagic vacuoles containing damaged mitochondria, decreased p62 levels, and increased levels of light-chain-3 (LC3)-II, an autophagy marker. In contrast, SPRED2 deficiency increased p62 levels and decreased LC3-II levels. SPRED2 expression levels were negatively correlated with translocase of outer mitochondrial membrane 20 (TOM20) expression levels, suggesting its role in mitophagy. Mechanistically, SPRED2 overexpression reduced ERK activation followed by the mechanistic or mammalian target of rapamycin complex 1 (mTORC1)-mediated signaling pathway, and SPRED2 deficiency showed the opposite pattern. Finally, hepatic autophagy was impaired in the liver of SPRED2-deficient mice with hepatic lipid droplet accumulation in response to starvation. These results indicate that SPRED2 is a critical regulator of autophagy not only in HCC cells, but also in hepatocytes, and thus the manipulation of this process may provide new insights into liver pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyCarcinoma, HepatocellularHepatocytesLiver NeoplasmsAnimalsHumansMiceCell Line, TumorMAP Kinase Signaling SystemMechanistic Target of Rapamycin Complex 1MitophagyRepressor Proteins

Stichwörter der Autor:innen

MAPK/ERKSPRED proteinsautophagyhepatocellular carcinomamTORmitophagy

Substanzen

Mechanistic Target of Rapamycin Complex 1Repressor ProteinsSPRED2 protein, humanSpred2 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
  • Department of Cell Biology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.

ORCID-Profile: Toshiaki Ohara, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Wang, T., Gao, T., Fujisawa, M., Ohara, T., Sakaguchi, M., Yoshimura, T., & Matsukawa, A. (2024). SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116269

Vancouver

Wang T, Gao T, Fujisawa M, Ohara T, Sakaguchi M, Yoshimura T, et al. SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116269

BibTeX
@article{Wang2024,
  author = {Wang, Tianyi and Gao, Tong and Fujisawa, Masayoshi and Ohara, Toshiaki and Sakaguchi, Masakiyo and Yoshimura, Teizo and Matsukawa, Akihiro},
  title = {SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25116269}
}
Kostenlos starten →